Terms: = Lung cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758
188 results:
1. 5-Hydroxymethylcytosine in Cell-Free DNA Predicts Immunotherapy Response in lung cancer.
Shao J; Xu Y; Olsen RJ; Kasparian S; Sun K; Mathur S; Zhang J; He C; Chen SH; Bernicker EH; Li Z
Cells; 2024 Apr; 13(8):. PubMed ID: 38667328
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic Model for High-Grade Neuroendocrine Carcinoma of the lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
Kim HS; Kim JK; Lee JH; Lee YJ; Lee GK; Han JY
JCO Precis Oncol; 2024 Apr; 8():e2300495. PubMed ID: 38635931
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of 25 surgical cases of thymic neuroendocrine tumors and thymic carcinoma.
Midorikawa K; Miyahara S; Nishino N; Ueda Y; Waseda R; Shiraishi T; Sato T
J Cardiothorac Surg; 2024 Apr; 19(1):225. PubMed ID: 38627811
[TBL] [Abstract] [Full Text] [Related]
4. Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification.
Wang X; Zhang Z; Ding Y; Chen T; Mucci L; Albanes D; Landi MT; Caporaso NE; Lam S; Tardon A; Chen C; Bojesen SE; Johansson M; Risch A; Bickeböller H; Wichmann HE; Rennert G; Arnold S; Brennan P; McKay JD; Field JK; Shete SS; Le Marchand L; Liu G; Andrew AS; Kiemeney LA; Zienolddiny-Narui S; Behndig A; Johansson M; Cox A; Lazarus P; Schabath MB; Aldrich MC; Hung RJ; Amos CI; Lin X; Christiani DC
Genome Med; 2024 Feb; 16(1):22. PubMed ID: 38317189
[TBL] [Abstract] [Full Text] [Related]
5. Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls.
Zhao X; Yang M; Fan J; Wang M; Wang Y; Qin N; Zhu M; Jiang Y; Gorlova OY; Gorlov IP; Albanes D; Lam S; Tardón A; Chen C; Goodman GE; Bojesen SE; Landi MT; Johansson M; Risch A; Wichmann HE; Bickeböller H; Christiani DC; Rennert G; Arnold SM; Brennan P; Field JK; Shete S; Le Marchand L; Liu G; Hung RJ; Andrew AS; Kiemeney LA; Zienolddiny S; Grankvist K; Johansson M; Caporaso NE; Woll PJ; Lazarus P; Schabath MB; Aldrich MC; Patel AV; Davies MPA; Ma H; Jin G; Hu Z; Amos CI; Shen H; Dai J
Cancer; 2024 Mar; 130(6):913-926. PubMed ID: 38055287
[TBL] [Abstract] [Full Text] [Related]
6. Multi-classification model incorporating radiomics and clinic-radiological features for predicting invasiveness and differentiation of pulmonary adenocarcinoma nodules.
Sun H; Zhang C; Ouyang A; Dai Z; Song P; Yao J
Biomed Eng Online; 2023 Nov; 22(1):112. PubMed ID: 38037082
[TBL] [Abstract] [Full Text] [Related]
7. Vegetarian diets and risk of all-cause mortality in a population-based prospective study in the United States.
Blackie K; Bobe G; Takata Y
J Health Popul Nutr; 2023 Nov; 42(1):130. PubMed ID: 37996932
[TBL] [Abstract] [Full Text] [Related]
8. Using Radiomics to Differentiate Brain Metastases From lung cancer Versus Breast cancer, Including Predicting Epidermal Growth Factor Receptor and human Epidermal Growth Factor Receptor 2 Status.
Shi J; Chen H; Wang X; Cao R; Chen Y; Cheng Y; Pang Z; Huang C
J Comput Assist Tomogr; 2023 Nov-Dec 01; 47(6):924-933. PubMed ID: 37948368
[TBL] [Abstract] [Full Text] [Related]
9. Sinoatrial Node Dose Is Associated With Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central lung cancers.
Iovoli AJ; Yu H; Advani PG; Turecki L; Malhotra HK; Malik NK; Fung-Kee-Fung S; Singh AK; Farrugia MK
Pract Radiat Oncol; 2024; 14(1):e40-e47. PubMed ID: 37804882
[TBL] [Abstract] [Full Text] [Related]
10. Progression before local control in osteosarcoma: Outcome and prognosis-predictive factors.
Halalsheh H; Amer S; Sultan I
Pediatr Blood Cancer; 2023 Nov; 70(11):e30649. PubMed ID: 37638816
[TBL] [Abstract] [Full Text] [Related]
11. Cost Effectiveness and Budget Impact of Nivolumab Plus Ipilimumab Versus Platinum Plus Pemetrexed (with and Without Bevacizumab) in Patients with Unresectable Malignant Pleural Mesothelioma in Switzerland.
Barbier MC; Fengler A; Pardo E; Bhadhuri A; Meier N; Gautschi O
Pharmacoeconomics; 2023 Dec; 41(12):1641-1655. PubMed ID: 37572261
[TBL] [Abstract] [Full Text] [Related]
12. Risk factors associated with atrial fibrillation following lung cancer surgery: A multi-center case-control study.
Zhang L; Li X; Wu H; Luo J
Asian J Surg; 2024 Jan; 47(1):176-183. PubMed ID: 37419802
[TBL] [Abstract] [Full Text] [Related]
13. Clinical effect of surgical treatment for lung metastasis and prognostic risk factor analysis: a single-centred cohort study.
Peng D; Sun W
ANZ J Surg; 2023 Jun; 93(6):1551-1558. PubMed ID: 37226585
[TBL] [Abstract] [Full Text] [Related]
14. A strategy to reduce the false-positive rate after low-dose computed tomography in lung cancer screening: A multicenter prospective cohort study.
Wu Z; Tan F; Xie Y; Tang W; Wang F; Xu Y; Cao W; Qin C; Dong X; Zheng Y; Luo Z; Wang C; Zhao L; Xia C; Li J; Li R; Feng F; Li J; Ren J; Shi J; Cui H; Shen S; Wu N; Chen W; Li N; He J
Cancer Med; 2023 Jul; 12(13):14781-14793. PubMed ID: 37199391
[TBL] [Abstract] [Full Text] [Related]
15. Assessment of bone-targeting agents use in patients with bone metastasis from breast, lung or prostate cancer using structured and unstructured electronic health records from a regional UK-based hospital.
Seesaghur A; Egger P; Warden J; Abbasi A; Levick B; Riaz M; McMahon P; Thompson M; Cheeseman S
BMJ Open; 2023 May; 13(5):e069214. PubMed ID: 37156580
[TBL] [Abstract] [Full Text] [Related]
16. The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery.
Hou Z; Zhao L; Zou L; Li B
Adv Clin Exp Med; 2023 Aug; 32(8):847-853. PubMed ID: 36881364
[TBL] [Abstract] [Full Text] [Related]
17. Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell lung cancer.
Chen YH; Lue KH; Lin CB; Chen KC; Chan SC; Chu SC; Chang BS; Chen YC
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835402
[TBL] [Abstract] [Full Text] [Related]
18. A contrast-enhanced MRI-based nomogram to identify lung metastasis in soft-tissue sarcoma: A multi-centre study.
Hu Y; Wang H; Yue Z; Wang X; Wang Y; Luo Y; Jiang W
Med Phys; 2023 May; 50(5):2961-2970. PubMed ID: 36433749
[TBL] [Abstract] [Full Text] [Related]
19. Visible- and near-infrared hyperspectral imaging for the quantitative analysis of PD-L1+ cells in human lymphomas: Comparison with fluorescent multiplex immunohistochemistry.
Brunner A; Willenbacher E; Willenbacher W; Zelger B; Zelger P; Huck CW; Pallua JD
Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121940. PubMed ID: 36208576
[TBL] [Abstract] [Full Text] [Related]
20. Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell lung cancer: The ASTRUM-005 Randomized Clinical Trial.
Cheng Y; Han L; Wu L; Chen J; Sun H; Wen G; Ji Y; Dvorkin M; Shi J; Pan Z; Shi J; Wang X; Bai Y; Melkadze T; Pan Y; Min X; Viguro M; Li X; Zhao Y; Yang J; Makharadze T; Arkania E; Kang W; Wang Q; Zhu J;
JAMA; 2022 Sep; 328(12):1223-1232. PubMed ID: 36166026
[TBL] [Abstract] [Full Text] [Related]
[Next]
